Loading patent…
AssigneeSociete des Produits Nestle S.A.
InventorLaurent FERRIER
Estimating the term…
The present invention relates to a combination of galacto-oligosaccharides (GOS) and a mix of human oligosaccharides (HMOs), or nutritional compositions comprising the combination, for use in promoting sleep and/or treating and/or preventing sleep disorders in a subject, wherein the mix consists of 2′-fucosyllactose (2′FL) and difucosyllactose (DFL) or lacto-N-tetraose (LNT) and 6′-sialyllactose (6′SL). The present invention also relates to the use of a combination of galacto-oligosaccharides (GOS) and a mix of human oligosaccharides (HMOs), or nutritional compositions comprising the combination, for use in promoting sleep and/or treating and/or preventing sleep disorders in a subject, wherein the mix consists of 2′-fucosyllactose (2′FL) and difucosyllactose (DFL) or lacto-N-tetraose (LNT) and 6′-sialyllactose (6′SL). Furthermore, the present invention relates to a method for in promoting sleep and/ or in treating and/or preventing sleep disorders in a subject, the method comprising administering to the subject a combination or a nutritional composition according to the invention.
A method of promoting sleep and/or treating and/or preventing a sleep disorder in a subject, the method comprising administering a combination of galacto-oligosaccharides (GOS) and a mix of human milk oligosaccharides (HMOs) to the subject, wherein the mix of HMOs consists of 2′-fucosyllactose (2′FL) and difucosyllactose (DFL) or lacto-N-tetraose (LNT) and 6′-sialyllactose (6′SL).
(canceled)
A method for increasing production of melatonin by the gut of a subject, the method comprising administering to the subject a combination of galacto-oligosaccharides (GOS) and a mix of human milk oligosaccharides (HMOs), wherein the mix of HMOs consists of 2′-fucosyllactose (2′FL) and difucosyllactose (DFL) or lacto-N-tetraose (LNT) and 6′-sialyllactose (6′SL).
Dependencies are inferred from the claim text.